For the past fifteen years, Western Medicine has had a class of drugs called anti-vascular endothelial growth factor (anti-VEGF) drugs to treat wet Age-Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR). 

These drugs work by reducing the production of a signaling protein called vascular endothelial growth factor(VEGF).

Decreased VEGF leads to fewer immature blood vessels in the retina/macula and thus cuts down on the risk of retinal vascular bleeds that can rapidly diminish central vision.

Eye Injection Medications 

Currently, there are three anti-VEGF drugs available. Two of these, ranibizumab (brand name Lucentis) and aflibercept (brand name Eylea) were developed specifically to treat AMD and DR. 

These drugs are effective but quite expensive. The third, bevacizumab (brand name Avastin), was originally developed to treat various types of cancer but is also used off label for AMD and DR.

A fourth anti-VEGF drug, Brolucizumab is now in trials that may extend the time between dosing. In the United States Avastin is the first-line drug in most cases because it is more affordable.

Often the injections are done at least monthly until fluid is resolved and then injection frequency is decreased. Since Avastin is most commonly used, let’s take a closer look.

Like we mentioned it was originally developed as a chemotherapy drug for gastrointestinal cancers.  It is highly toxic and at least 30% of patients experience significant side effects.

Side Effects Of Eye Injection Medications

These side effects include burst blood vessels in eyes, eye pain, cataract formation, increased intraocular pressure, vitreous detachment, floaters, light sensitivity, sudden numbness and weakness on the treated side.

The other problem with Avastin and other anti-VEGF drugs is that they are not stopping the progression of AMD or DM. By cutting down on new vessel growth to the macula and retina, which is most affected in AMD and DM respectfully, the photoreceptor cells in the macula and retina are starved leading to further nerve death.

The injections do not address the starving cells and thus further vision loss in both AMD and DR often occurs with anti-VEGF injections.

There is no doubt that anti-VEGF drugs can help significantly inactive retinal bleeding situations and curtail acute vision loss but in the long term these drugs can create an environment that promotes vision loss.

Micro-Acupuncture To Treat Degenerative Eye Conditions

Micro-acupuncture has been used safely on thousands of patients with age-related macular degeneration and diabetic retinopathy to address vision loss.

The signaling protein VEGF is produced in the body as a response to the retina and macula not getting enough nourishment and oxygen as well as the buildup of retinal waste products (Drusen). 

How Micro- Acupuncture Works

The micro-acupuncture signals to the brain to improve blood flow to the retina and macula. This treatment naturally reduces the production of signaling protein VEGF via the improved profusion.

The end result is that new blood vessel growth is cut down leading to a decreased risk of retinal bleeds.

This is how micro-acupuncture can improve vision and decrease the risk of retinal/macula bleeds without exposure to toxic pharmaceuticals. 

The micro-acupuncture helps the body heal itself. If you prefer a holistic and highly effective way to address your vision loss please call our office to set up a free consultation.